EANS-Adhoc: CURANUM AG / Capital increase placed successfully

ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement.

03.05.2011

Curanum AG, which is listed in the Prime Standard, has placed 6,532,000 new shares among shareholders on the basis of the subscription offer that was published in the electronic Federal Gazette on April 11, 2011. Interest in the new shares significantly exceeded the offering volume due to shareholders' oversubscription requests. For this reason, not all shareholders' oversubscription requests could be fully considered. Shareholders' oversubscription requests received allocations in proportion to their subscription right entitlements in line with the principle of equal treatment. Information about the oversubscription will be published on Curanum's website at www.curanum.de/Investor Relations/Capital Increase on May 4, 2011.

Curanum AG's share capital is raised from currently EUR 32,660,000.00 to EUR 39,192,000.00 as a result of the capital increase. The capital increase will generate gross issue proceeds of around EUR 11,757,600 less placement costs for Curanum AG. The company will deploy the cash inflow to continue on its growth path.

The new shares are to be admitted to trading prospectively in the 20th calendar week following the shortly forthcoming entry of the capital increase in the commercial register, and the new shares will be delivered subsequently.

end of announcement euro adhoc

issuer: CURANUM AG Engelbertstraße 23-25 D-81241 München phone: +49 (0)89 242065 0 FAX: +49 (0) 89 242065 10 mail: info@curanum.de WWW: http://www.curanum.de sector: Healthcare Providers ISIN: DE0005240709 indexes: CDAX, Classic All Share, Prime All Share

stockmarkets: regulated dealing/prime standard: Frankfurt, free trade: Berlin, Hamburg, Stuttgart, Düsseldorf, regulated dealing: München language: English

Rückfragen & Kontakt:

Caroline Lutz
Tel.: + 49 89 242065 17
E-Mail: ir@curanum.de

OTS-ORIGINALTEXT PRESSEAUSSENDUNG UNTER AUSSCHLIESSLICHER INHALTLICHER VERANTWORTUNG DES AUSSENDERS | OTB0027